Amgen Inc
Change company Symbol lookup
Select an option...
AMGN Amgen Inc
LGHL Lion Group Holding Ltd
EXEL Exelixis Inc
LBTYA Liberty Global PLC
TDOC Teladoc Health Inc
BRSH Bruush Oral Care Inc
RNA Avidity Biosciences Inc
ATAI ATAI Life Sciences NV
VTI Vanguard Total Stock Market Index Fund ETF Shares
AMPS Altus Power Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Premarket

Last Trade
Delayed
$241.40
-0.10 (-0.04%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$241.50
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
5

10-day average volume:
2,734,503
5
  • Prev Close
    241.50
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    2.7M
  • Last (time)
    4:00p ET 03/30/23
  • Last (size)
    5
  • 52-Wk Range
    223.30 - 296.67
    LowHigh
  • (09/22/22 - 11/08/22)
    8.15%
  • 20.8%
  • Market Cap
    129.0B
  • Shares Outstanding
    534.0M
  • 12.12
  • 19.89x
  • $8.52/3.53%
  • Ex-dividend Date
    05/17/23
  • Dividend Pay Date
    06/08/23
  • 0.6
  • 75.99
  • (% of float 03/15/23)
    1.43

Latest News

March 31, 2023
5:45 am ET
PR Newswire
March 30, 2023
10:32 pm ET
Newsfile
8:36 pm ET
Globe Newswire
7:37 pm ET
Newsfile
7:02 pm ET
Globe Newswire
6:00 pm ET
PR Newswire
4:37 pm ET
MarketWatch
11:58 am ET
Globe Newswire
5:45 am ET
PR Newswire
March 29, 2023
10:24 pm ET
Newsfile
8:44 pm ET
Globe Newswire
6:51 pm ET
Accesswire
5:23 pm ET
Newsfile
4:37 pm ET
MarketWatch
3:54 pm ET
Newsfile
11:04 am ET
Accesswire
10:40 am ET
Accesswire
5:45 am ET
PR Newswire
1:46 am ET
Newsfile
March 28, 2023
10:23 pm ET
Accesswire
8:47 pm ET
Newsfile
7:18 pm ET
Newsfile
4:37 pm ET
MarketWatch
4:24 pm ET
Accesswire
11:00 am ET
Accesswire
5:45 am ET
PR Newswire
March 27, 2023
9:00 pm ET
Globe Newswire
8:23 pm ET
Accesswire
4:37 pm ET
MarketWatch
4:10 pm ET
Newsfile
1:04 pm ET
Accesswire
12:55 pm ET
Accesswire
11:36 am ET
Newsfile
10:00 am ET
Globe Newswire
9:00 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.